Attenuation of the Wnt/β-catenin/TCF pathway by in vivo interferon-α2b (IFN-α2b) treatment in preneoplastic rat livers

References

• Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. 1997. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:3797–3804.
   PubMed Web of Science ®Google Scholar
• Alvarez ML, Quiroga AD, Parody JP, Ronco MT, Frances DE, Carnovale CE, Carrillo MC. 2009. Cross-talk between IFN-alpha and TGF-beta1 signaling pathways in preneoplastic rat liver. Growth Factors. 27:1–11.
   PubMed Web of Science ®Google Scholar
• Behrens J, Jerchow BA, Würtele M, Grimm J, Asbrand C, Wirtz R, Kühl M, Wedlich D, Birchmeier W. 1998. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science. 280:596–599.
   PubMed Web of Science ®Google Scholar
• BellanC, De, Falco G, Tosi GM, Lazzi S, Ferrari F, Morbini G, BartolomeiS, Toti P, Mangiavacchi P, Cevenini G, Trimarchi C, Cinti C, Giordano A, Leoncini L, Tosi P, Cottier H. 2002. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. Invest Ophthalmol Vis Sci. 43:3602–3608.
   PubMed Web of Science ®Google Scholar
• Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. 1999. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 155:1033–1038.
   PubMed Web of Science ®Google Scholar
• Bruix J, Boix L, Sala M, Llovet JM. 2004. Focus on hepatocellular carcinoma. Cancer Cell. 5:215–219.
   PubMed Web of Science ®Google Scholar
• Burgering BM, Kops GJ. 2002. Cell cycle and death control: Long live forkheads. Trends Biochem Sci. 27:352–360.
   PubMed Web of Science ®Google Scholar
• Cadigan KM, Nusse R. 1997. Wnt signaling: A common theme in animal development. Genes Dev. 11:3286–3305.
   PubMed Web of Science ®Google Scholar
• Calvisi DF, Factor VM, Loi R, Thorgeirsson SS. 2001. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: Relationship to phenotype and tumor grade. Cancer Res. 61:2085–2091.
   PubMed Web of Science ®Google Scholar
• Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H, Peifer M, Bejsovec A.. 1998. Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature. 395:604–608.
   PubMed Web of Science ®Google Scholar
• Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. 1999. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene. 18:4726–4733.
   PubMed Web of Science ®Google Scholar
• Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ. 2000. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol. 10:1201–1204.
   PubMed Web of Science ®Google Scholar
• Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC. 2005. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science. 308:1181–1184.
   PubMed Web of Science ®Google Scholar
• Fujimura N, Vacik T, Machon O, Vlcek C, Scalabrin S, Speth M, Diep D, Krauss S, Kozmik Z. 2007. Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5. J Biol Chem. 282:1225–1237.
   PubMed Web of Science ®Google Scholar
• Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N. 2005. FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal. 7:752–760.
   PubMed Web of Science ®Google Scholar
• Gautschi O, Ratschiller D, Gugger M, Betticher DC, Heighway J. 2007. Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation. Lung Cancer. 55:1–14.
   PubMed Web of Science ®Google Scholar
• Gutterman JU. 1994. Cytokine therapeutics: Lessons from interferon alpha. Proc Natl Acad Sci USA. 91:1198–1205.
   PubMed Web of Science ®Google Scholar
• Hart MJ, de los Santos R, Albert IN, Rubinfeld B, PolakisP. 1998. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol. 8:573–581.
   PubMed Web of Science ®Google Scholar
• Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM, Burgering BM. 2008. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J Biol Chem. 283:9224–9230.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Fukuda M, KoidaI, Arase Y, Chayama K, Murashima N, Kumada H.. 1998. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: A pilot study. Cancer. 82:827–835.
   PubMed Web of Science ®Google Scholar
• Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. 2002. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 22:1172–1183.
   PubMed Web of Science ®Google Scholar
• Kornmann M, Danenberg KD, Arber N, Beger HG, Danenberg PV, Korc M. 1999. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res. 59:3505–3511.
   PubMed Web of Science ®Google Scholar
• Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, Groner Y. 1998. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci USA. 95:11590–11595.
   PubMed Web of Science ®Google Scholar
• Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X. 2002. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 108:837–847.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
   PubMed Web of Science ®Google Scholar
• Mao J, Wang J, Liu B, Pan W, Farr GH3rd, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D. 2001. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell. 7:801–809.
   PubMed Web of Science ®Google Scholar
• Merle P, de la, Monte S, Kim M, Herrmann M, Tanaka S, Von Dem, Bussche A, Kew MC, Trepo C, Wands JR. 2004. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology. 127:1110–1122.
   PubMed Web of Science ®Google Scholar
• Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR. 2005. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J Hepatol. 43:854–862.
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T, Nakamura Y. 1998. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 58:2524–2527.
   PubMed Web of Science ®Google Scholar
• Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1787–1790.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108.
   PubMed Web of Science ®Google Scholar
• Parody JP, Alvarez ML, Quiroga A, Ronco MT, Frances D, Carnovale C, Carrillo MC. 2007. Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity. Arch Toxicol. 81:565–573.
   PubMed Web of Science ®Google Scholar
• Pfeffer LM. 1997. Biologic activities of natural and synthetic type I interferons. Semin Oncol. 24:S9.
   PubMed Web of Science ®Google Scholar
• Pitot HC. 1990. Altered hepatic foci: Their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol. 30:465–500.
   PubMed Web of Science ®Google Scholar
• Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT. 1993. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res. 53:417–422.
   PubMed Web of Science ®Google Scholar
• Quiroga AD, Alvarez ML, Parody JP, Ronco MT, Frances DE, Pisani GB, Carnovale CE, Carrillo MC. 2007. Involvement of reactive oxygen species on the apoptotic mechanism induced by IFN-alpha2b in rat preneoplastic liver. Biochem Pharmacol. 73:1776–1785.
   PubMed Web of Science ®Google Scholar
• Quiroga AD, de Lujan Alvarez M, Parody JP, Ronco MT, Carnovale CE, Carrillo MC. 2009. Interferon-alpha2b (IFN-alpha2b)-induced apoptosis is mediated by p38 MAPK in hepatocytes from rat preneoplastic liver via activation of NADPH oxidase. Growth Factors. 27.
   Web of Science ®Google Scholar
• Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. 1997. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science. 275:1790–1792.
   PubMed Web of Science ®Google Scholar
• Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 96:5522–5527.
   PubMed Web of Science ®Google Scholar
• Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X. 2000. LDL-receptor-related proteins in Wnt signal transduction. Nature. 407:530–535.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Kato K, Notohara K, Hojo H, Ijiri R, Miyake T, Nagahara N, Sasaki F, Kitagawa N, Nakatani Y, Kobayashi Y. 2001. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res. 61:8401–8404.
   PubMed Web of Science ®Google Scholar
• Thorgeirsson SS, Grisham JW. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 31:339–346.
   PubMed Web of Science ®Google Scholar
• Willert J, Epping M, Pollack JR, Brown PO, Nusse R. 2002. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol. 2:8.
   PubMedGoogle Scholar
• Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. 1997. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA. 94:1402–1407.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Itoh F, Hinoda Y, Imai K. 1995. Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int J Cancer. 61:218–222.
   PubMed Web of Science ®Google Scholar
• Yanagawa S, van Leeuwen F, Wodarz A, Klingensmith J, Nusse R. 1995. The dishevelled protein is modified by wingless signaling in Drosophila. Genes Dev. 9:1087–1097.
   PubMed Web of Science ®Google Scholar
• Yanagawa S, Matsuda Y, Lee JS, Matsubayashi H, Sese S, Kadowaki T, Ishimoto A. 2002. Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila. EMBO J. 21:1733–1742.
   PubMed Web of Science ®Google Scholar
• Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH, Fuller JH, Reinhard C, Garcia PD, Randazzo FM, Escobedo J, Fantl WJ, Williams LT. 2001. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA. 98:14973–14978.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G, Omata M. 1999. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy. Ann Intern Med. 131:174–181.
   PubMed Web of Science ®Google Scholar
• Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F. 1997. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell. 90:181–192.
   PubMed Web of Science ®Google Scholar
• Zurita M, Cabrera MM, Morales C, Oya S, Vaquero J. 1994. Influence of the postnatal administration of tumor necrosis factor plus interferon-alpha 2b on the development of ethyl-nitrosourea-induced brain tumors in rats. Neurosci Lett. 174:213–216.
   PubMed Web of Science ®Google Scholar
• de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. 1998. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA. 95:8847–8851.
   PubMed Web of Science ®Google Scholar
• de Luján Alvarez M, Cerliani JP, Monti J, Carnovale C, Ronco MT, Pisani G, Lugano MC, Carrillo MC. 2002. The in vivo apoptotic effect of interferon alfa-2b on rat preneoplastic liver involves Bax protein. Hepatology. 35:824–833.
   PubMed Web of Science ®Google Scholar
• de Luján Alvarez M, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, Pisani GB, Lugano MC, Carrillo MC. 2004. Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology. 40:394–402.
   PubMed Web of Science ®Google Scholar